Furiex Pharmaceuticals Inc

(Inactive)  
Find more results for FURX

Address

3900 Paramount Pkwy Ste 150
MORRISVILLE, NC 27560-5401
United States - Map
+1-919-4567800 (Phone)
+1-302-6365454 (Fax)

Website links

Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�s product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V. Effective July 2, 2014 Forest Laboratories Inc, a unit of Actavis PLC, acquired the entire share capital of Furiex Pharmaceuticals Inc.